Transcription Factors in Lymphocyte Development— T and B Cells Get Together  by Glimcher, Laurie H. & Singh, Harinder
Cell, Vol. 96, 13±23, January 8, 1999, Copyright 1999 by Cell Press
Transcription Factors in Meeting Review
Lymphocyte DevelopmentÐ
T and B Cells Get Together
surface proteins B220 and CD19 are generated (re-
viewed by Melchers et al., 1995). These proteins serve
as early B lineage developmental markers and execute
important functions in mature B cells. An early program
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locus, which also appears to require developmentally
programmed chromatin alterations associated with
transcription of constant and variable germline (unre-
Immunologists who study lymphocyte development arranged) gene segments.
tend to identify themselves with either the ªTº or ªBº The hematopoietic transcription factor PU.1 is an Ets
lymphocyte. In recent years, however, it has become family member that is uniquely required for the genera-
clear that the transcription factors that control lineage tion of the lymphoid±myeloid system. It functions in a
specification are much more promiscuous than those cell-autonomous manner to control the differentiation
who study them. Researchers working on transcription of multipotential lymphoid±myeloid progenitors (Scott
factors in both T and B lymphocyte development gath- et al., 1997). The PU.1 mutation results in a reduction of
ered together for what is probably the first time to dis- multipotential lymphoid±myeloid progenitors (AA4.11
cuss recent developments in the field (Madrid, October Lin2) in the fetal liver, and these mutant cells fail to
19±21, 1998). The meeting was organized by J. M. Re- generate B cells or macrophages in vitro. These results
dondo (Centro de Biologia Molecular ªSevero Ochoa,º support the view that the lymphoid and myeloid lineages
Madrid), S. Pettersson (Karolinska Institute, Stockholm) develop from a common hematopoietic progenitor not
and P. Matthias (Friedrich Miescher Institute, Basel) and shared with erythrocytes and megakaryocytes (Singh,
held at the Juan March Foundation in Madrid, Spain. 1996) (Figure 1). PU.1 controls macrophage develop-
Specification of the B Lineage ment by regulating both proliferation and differentiation
In the past five years, enormous progress has been of macrophage progenitors (DeKoter et al., 1998). It reg-
made in identifying transcription factors involved in the ulates the transcription of the M-CSF receptor (c-fms)
specification of the B lineage (reviewed by Reya and gene and therefore the responsiveness of macrophage
Grosschedl, 1998). Gene targeting experiments have re- progenitors to M-CSF. H. Singh presented data that
vealed a set of five transcription factors, PU.1, Ikaros, suggested analogous functions for PU.1 in B cell devel-
E2A, EBF, and Pax5, that are essential for the generation opment. PU.12/2 hematopoietic progenitors fail to ex-
or differentiation of B cell progenitors. Of these five press the IL-7 receptor because of an inability to induce
regulatory proteins, the activity or expression of three, the expression of the IL-7Ra gene. Such progenitors
E2A, EBF, and Pax5, is specifically regulated within the also do not express transcripts for the B lineage regula-
B lineage of the hematopoietic system. Presentations tors EBF and Pax5. Retroviral transduction of PU.1
at the meeting on these transcription factors provided cDNA into mutant progenitors induces IL-7 respon-
new insight into the hierarchical ordering of their devel- siveness and the generation of B2201CD191 B cell pro-
opmental functions and their roles in inducing or en- genitors expressing the genes mb-1, B29, l5, and
abling lineage specification. Furthermore, experiments VpreB. Thus, the block to B cell development caused
involving distinct approaches with the factors PU.1, E2A, by the PU.1 mutation may be due to the combined de-
and Pax5 provided new evidence for a close develop- fects in IL-7 signaling as well as the failure to induce
mental relationship between the lymphoid and myeloid expression of EBF and Pax5.
lineages, particularly between B cells and macrophages Signaling by IL-7R has been shown to regulate both
(Figure 1). Thus, this unique combination of five regula- proliferation and differentiation of B cell progenitors
tors may be both necessary and sufficient to induce the (Corcoran et al., 1998). Intriguingly, this study suggested
generation of B cell progenitors from a multipotential that Pax5 expression in pro±B cells may be regulated
by IL-7 signaling. Thus, PU.1 may indirectly regulatelymphoid±myeloid progenitor.
Pax5 expression by controlling IL-7 responsiveness.Specification of B lineage cells appears to be induced
Failed expression of the IL-7R may partly account forby the interaction of lymphoid or lymphoid±myeloid pro-
the absence of T cell progenitors in PU.12/2 embryos.genitors with stromal cells in hematopoietic tissue in
IL-7 is required for both B and T cell development andconjunction with IL-7 signaling. As a consequence of
IL-7R is expressed on a common lymphoid progenitorthese interactions, B cell progenitors expressing the cell
(Kondo et al., 1997). It should be noted that expression
of IL-7R in developing T cells is likely regulated in a
PU.1-independent manner since expression of the PU.1§ To whom correspondence should be sent (email: lglimche@
hsph.harvard.edu). gene is virtually undetectable in the thymus.
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Figure 1. A Regulatory Model for B Cell Development
The E2A gene encodes two basic helix-loop-helix vitro in the presence of stromal cells and IL-7. They
express wild-type levels of PU.1, Ikaros, E2A, and EBF(bHLH) proteins, E12 and E47, which are generated by
alternative splicing. Both proteins act in concert to pro- transcripts. Furthermore, expression of Rag1, Rag2, and
the surrogate light chain genes is unimpaired. However,mote B cell development (Bain et al., 1997). Very few
B2201 B cell progenitors are generated in E2A2/2 mice. Pax5 mutant pro±B cells express low levels of mb-1 and
do not induce CD19 expression. Pax5 directly regulatesSuch cells are blocked for Ig heavy chain gene re-
arrangement and fail to express Rag1, mb-1, l5, and transcription of these two B cell±specific genes (Nutt et
al., 1998). Finally, Pax5 mutant pro±B cells are selec-CD19 transcripts. C. Murre described ectopic, gain-of-
function experiments with the E12 gene product that tively impaired for V to DJ recombination at the IgH
locus, a phenotype that is also associated with the IL-suggested that E2A regulates EBF expression (Kee and
Murre, 1998). He showed that conversion of the pre±B 7R mutation (Corcoran et al., 1998). Thus, as noted
above, IL-7R signaling may regulate Pax5 expression,cell line 70Z/3 into a macrophage-like cell was accompa-
nied by the loss of E2A and EBF activity. Ectopic expres- which in turn would control VH gene recombination by
a novel mechanism.sion of E12 in the macrophage-like cell induced B cell
differentiation, including the expression of the EBF, IL- M. Busslinger presented a series of collaborative ex-
periments with T. Rolink and F. Melchers analyzing the7Ra, l5, and Rag1 genes. Interestingly, ectopic expres-
sion of EBF resulted in the induction of a subset of developmental potential of Pax5 mutant pro±B cell
clones. Intriguingly, in spite of their significant differenti-E12-regulated genes. These experiments reinforce the
developmental linkage between B lymphocytes and ation down the B cell pathway, these mutant cells were
shown to be capable of giving rise to macrophages andmacrophages and suggest that the two differentiation
programs may be interconvertible by manipulating key osteoclasts in vitro as well as CD41 or CD81 T cells in
vivo. It should be noted that pro±B cells arrested by thetranscription factors (Figure 1). These results in conjunc-
tion with analysis of EBF function by the Grosschedl Rag2 mutation do not evidence such developmental
plasticity in vitro. These results have two important de-laboratory (Lin and Grosschedl, 1995; Sigvardsson et
al., 1997), suggest that E2A functions both upstream of velopmental implications. First, they argue that Pax5 is
necessary for commitment to the B lineage. In its ab-EBF by regulating its expression and also in concert
with EBF to induce B cell±specific gene expression (for sence, PU.1, Ikaros, E2A, and EBF generate B lineage
progenitors that retain T lymphoid and macrophage de-example, transcription of the surrogate light chain genes
VpreB and l5). velopmental potentials. Second, the results of Bus-
slinger and colleagues further strengthen the develop-The Pax5 gene encoding the transcription factor
BSAP appears to function later than PU.1, Ikaros, E2A, mental connection between the lymphoid and myeloid
lineages.and EBF in B cell development (Nutt et al., 1997; Theve-
nin et al., 1998). In Pax5 mutant bone marrow, B2201 B Figure 1 presents a regulatory model for B cell devel-
opment. This model envisages that B cell differentiationcell progenitors are generated but cannot differentiate
into pre±B cells. These mutant cells can proliferate in is initiated by interaction of a progenitor cell expressing
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PU.1, Ikaros, and IL-7R with stromal cells and IL-7. Stro- of immature IgM1 B cells. F. Melchers reviewed experi-
ments using pro±B cell cultures from Rag22/2 micemal contact via an undefined signaling pathway may
induce E2A activity (*E2A) in part by promoting the for- which indicate that this later program of B cell±specific
gene expression does not require signaling by the pre-mation of B lineage±specific homodimers. Induction of
E2A activity would then result in the expression of the BCR. Transcription factors regulating differentiation of
pre±B cells remain to be genetically elucidated. Imma-downstream regulator EBF. In this model, interaction
with stroma and signaling through IL-7R would also pro- ture B cells that are not reactive to autoantigens are
selected and mature into antigen-responsive, resting Bmote the expression of the remaining B lineage regulator
Pax5. All of these transcription factors functioning in cells (Figure 2). P. Matthias described experiments with
OCA-B/OBF-1 mutant mice that suggested a role fordistinct combinations could induce the early program
of B cell gene expression including the genes mb-1, this regulatory protein in B cell maturation. OCA-B is a
B cell±specific coactivator that interacts with the POUB29, l5, VpreB, CD19, Rag1, and Rag2. Similar scenar-
ios based on the induction of a small set of key transcrip- domain transcription factors Oct1 and Oct2 (see below).
Using a monoclonal antibody (MAb493) that distin-tion factors can be proposed for the development of
macrophage and T lineage progenitors. However, for guishes the developing B cell compartment in the bone
marrow from peripheral mature B cells, P. Matthias inthese lineages fewer regulators have been described
that function in specification. Induction of PU.1 gene collaboration with T. Rolink and F. Melchers showed
that OCA-B appears to be required for the exit of B cellsexpression (*PU.1) may induce macrophage differentia-
tion since PU.1 is expressed at significantly higher levels from the bone marrow into the periphery. The splenic
B cells that accumulate in OCA-B2/2 mice appear to bein the monocytic versus the B lineage (H. Singh). Finally,
induction of GATA3 expression (*GATA3) may induce T generated during fetal development as they are elimi-
nated in OCA-B2/2 mice that are also deficient in thecell differentiation (see below). It should be noted that
in this model graded levels of PU.1 expression may tyrosine kinase Btk, which is required for the generation
of CD51 B cells.participate in cell fate decisions (i.e., high levels favoring
macrophage development; intermediate levels, B cell Upon encountering cognate antigen, a naive B cell is
stimulated to proliferate via signaling through its BCR,development; and its absence, T cell development).
The Ikaros gene encodes a family of zinc finger tran- surface IgM (sIgM). The antigen is endocytosed, proteo-
lytically processed, and presented to T helper (Th) cells.scription factors that are essential for the generation of
fetal B and T cell progenitors (Wang et al., 1996). Ikaros Extensive interactions of antigen-reactive B cells with
cognate Th cells and follicular dendritic cells then resultgene activity remains essential for adult B lymphopoie-
sis, but exhibits partial redundancy in postnatal T cell in the formation of germinal centers in secondary
lymphoid tissue (reviewed by MacLennan, 1994). Clonaldevelopment. K. Georgopoulos reported that Ikaros2/2
hematopoietic progenitors do not express transcripts proliferation of B cells in germinal centers is accompa-
nied by differentiation involving isotype switch recombi-for the FLK2 receptor, loss of which has previously been
shown to cause a severe reduction in B cell progenitors. nation (ISR) and somatic hypermutation (SHM) of Ig
genes (Figure 2). The process culminates in the genera-Although Ikaros proteins may function like PU.1 E2A,
EBF, and Pax5 to positively regulate the early program tion of memory B cells or Ig-secreting plasma cells.
Transcription factors regulating B cell proliferationof B cell±specific gene expression, a novel mechanism
has been proposed whereby Ikaros complexes function and differentiation can be divided into three functional
groupings: (1) factors (e.g., Aiolos, PU.1, and Spi-B) thatas repressors in lineage specification (Brown et al.,
1997). In nuclei of B lineage cells, Ikaros complexes regulate initial signaling events by the BCR perhaps by
controlling the expression of key signal transductionhave been colocalized with inactive T cell±specific
genes, such as CD4 and CD8, and heterochromatin foci. components, (2) factors that are activated upon signal-
ing (e.g., NF-kB/Rel proteins that induce downstreamAn implication of these results is that Ikaros proteins
may target genes expressed in developmentally related gene expression), and (3) factors whose expression is
induced upon B cell activation (e.g., OCA-B and Pip/lineages to heterochromatic nuclear domains for inacti-
vation. Thus, in the model outlined in Figure 1, Ikaros IRF-4). K. Georgopoulos described the effect of the Ai-
olos mutation on B cell activation and differentiation.complexes may initially function to repress inappropri-
ate myeloid gene expression in lymphoid progenitors Aiolos encodes an Ikaros-related zinc finger transcrip-
tion factor that is expressed at high levels in mature Band then participate in B and T cell specification by
inactivating T and B cell±specific loci, respectively. cells. Aiolos2/2 B cells hyperproliferate in response to
BCR engagement and also exhibit a lower threshold forTranscription Factors Regulating B Cell
Maturation and Activation activation (Wang et al., 1998). Aiolos-deficient mice form
germinal centers and have elevated serum IgG and IgE,Proper differentiation of pro±B cells results in productive
rearrangement of an Ig heavy chain allele (VHDHJH) and in the absence of immunization. Interestingly, reduction
of Ikaros activity in T cells results in a very similar cellexpression of the pre±B cell receptor (pre-BCR), com-
posed of the m heavy chain and the two surrogate light cycle activation phenotype as that caused by loss of
Aiolos in B cells. Thus, Aiolos and Ikaros appear tochains l5 and VpreB. Receptor feedback inhibits further
rearrangements of heavy chain variable gene segments regulate the G0 to G1 transition as well as subsequent
cell cycling. Their mechanisms of action remain to beand promotes proliferation (Figure 1). During this phase
surrogate light chain gene (l5 and VpreB) transcription elucidated.
Spi-B is an Ets family transcription factor that is highlyappears to be repressed. Cessation of pre±B cell prolif-
eration culminates in the induction of light chain gene related to PU.1. Spi-B2/2 mice exhibit attenuated T-depen-
dent immune responses (reduced serum IgG) that are(kappa or lambda) rearrangements and the generation
Cell
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Figure 2. Transcription Factors Regulating B Cell Activation
associated with defects in germinal center formation phosphorylated PU.1. H. Singh described a model for
and maintenance (Su et al., 1997). Spi-B2/2 B cells are PU.1/Pip ternary complex formation. In this model, PU.1/
defective in BCR-stimulated proliferation. This defect Pip interaction is DNA template-directed and involves
is exacerbated in Spi-B2/2, PU.11/2 B cells (C. Simon, two distinct protein±protein interaction surfaces: (1) the
personal communication). Molecular analysis of this de- Ets and IRF DNA-binding domains and (2) the phosphor-
fect suggests that Spi-B and PU.1 regulate expression of ylated PEST region of PU.1 and a lysine-requiring puta-
a novel membrane proximal BCR signaling component. tive a helix in Pip. To analyze the function of these
The B cell±specific coactivator OCA-B appears to reg- factors in vivo, the Singh laboratory engineered chimeric
ulate the activity of Ig gene promoters by associating repressors containing the Ets and IRF DNA-binding do-
with the POU domain transcription factors Oct1 or Oct2, mains connected by a flexible POU domain linker. When
which recognize the functionally essential octamer ele- stably expressed, the fused dimer strongly repressed
ment. Mutation of the OCA-B gene does not result in a the transcription of a rearranged Igl gene in a plasma
block to B cell development or diminished expression of cell line (Brass et al., 1998). Thus, Pip is dispensable for
IgM or IgD on mature B cells (Kim et al., 1996; Schubart light chain gene transcription during B cell development
et al., 1996). P. Matthias reported that B cells can be but may be required for enhanced expression of these
generated even in mice that lack both OCA-B and Oct2. genes during B cell activation.
These results suggest that the ubiquitous transcription A third highly specific ternary complex important for
activator Oct1 is sufficient to promote Ig gene transcrip- B cell±specific gene expression was reported by J. Hag-
tion during the antigen-independent phase of B cell de- man. This complex involves Pax5, which recruits spe-
velopment. Although OCA-B is not essential for B cell cific Ets family proteins (e.g., Ets1) to a composite ele-
development, it is required for immune responses against ment in the mb-1 gene promoter. In this case the
T-independent and T-dependent antigens. This appears complex requires only the Pax5 paired box and the Ets
to be caused by a failure to form germinal centers upon DNA binding domains (Fitzsimmons et al., 1996). By
immunization. Given the cell-autonomous requirement tethering deletion fragments of Pax5 to a heterologous
for OCA-B function and the synergistic induction of its DNA-binding domain, the Hagman laboratory has delin-
expression by signaling pathways that induce germinal
eated a 73±amino acid segment that is sufficient for Ets1
center formation, it has been proposed that OCA-B is
recruitment. This segment contains a highly conserved b
specifically required for the germinal center reaction
hairpin motif that also enables other Pax family members
(Qin et al., 1998). Key OCA-B target genes underlying
to interact with Ets factors (Wheat et al., 1999). Intrigu-such a function remain to be identified. P. Matthias pro-
ingly, Pax5 appears to negatively interact with the Etsposed a molecular model for the Oct1/OCA-B/DNA com-
factor PU.1 to modulate IgH gene transcription in B cells.plex that envisages OCA-B as a molecular clamp inter-
S. Pettersson reported that the IgH 39 enhancer containsacting with both subdomains of the bipartite POU
functionally important binding sites for Pax5 and PU.1domain (Sauter and Matthias, 1998). Site-directed muta-
separated by 44 bp. Pax5 was shown to repress en-genesis localized residues L6 and E7 in the POUS do-
hancer activity stimulated by PU.1. The mechanism un-main and K155 and I159 in the POUH domain as being
derlying this antagonistic interaction between Pax5 andcritical for ternary complex formation. Interestingly,
PU.1 remains to be elucidated.OCA-B can promote transactivation by recruiting artifi-
C. Murre described the cloning and characterizationcially separated POU domains to an octamer element
of a novel bHLH transcription factor, ABF1, expressedin vivo.
in activated B lymphocytes. ABF1 can bind E box motifsPip/IRF-4 is a lymphoid-restricted IRF transcription
in Ig gene enhancers either as a homodimer or as afactor that is recruited to composite elements within Ig
heterodimer with E2A proteins (Massari et al., 1998). Tolight chain enhancers through a specific interaction with
analyze the function of E2A complexes during B cellPU.1 (Brass et al., 1996). Mice deficient in Pip/IRF-4 can
activation, the Murre laboratory transiently expressedgenerate normal numbers of B cells that express IgM
Id3, a negative regulator of E2A proteins, in activated Bwith kappa or lambda light chains. However, these mice
cells. Expression of Id3 appears to selectively inhibitexhibit a dramatic reduction in serum Ig levels and do
Ig isotype switching. E2A complexes could potentiallynot mount detectable antibody responses to T-depen-
regulate isotype switching by binding to enhancer ele-dent as well as T-independent antigens (Mittrucker et
al., 1997). Pip is recruited to its binding site on DNA by ments at the 39 end of the IgH locus.
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Figure 3. Transcription Factors that Regu-
late Development of the T Cell Lineage
Specification of the T Lineage at the CD81 ISP stage (Okamura et al., 1998). Another
HMG family member, Sox4, is also critical in the transi-In the thymus, bone marrow±derived stem cells undergo
tion from the DN to the DP stage (van de Wetering eta programmed series of differentiation and selection
al., 1993). The presence of similar defects in Tcf1/Lef1steps that results in the generation of mature functional
and Sox4 mutant mice suggest that each of these threeCD41 and CD81 cells that are exported to the periphery
proteins is required for optimal proliferation and matura-(Figure 3). The earliest stage of thymocyte development
tion of DN thymocytes, and maintenance of the periph-is the so-called double-negative (DN) cell that lacks ex-
eral pool of mature T cells. How might this be accom-pression of both the CD3/TCR complex and the CD4
plished? Although Tcf1/Lef1 regulate the expression ofand CD8 coreceptors. DN cells then express the Rag1
the TCRa gene, downregulation of TCRa cannot ex-and -2 genes, rearrange the TCRb gene (CD3/TCR1) and
plain the block since TCRa expression is not requiredexpress CD4 and CD8 coreceptors to become double-
for the DN-to-DP transition. The answer may lie in thepositive (DP) cells. DP cells rearrange the TCRa gene
recent discovery, presented by H. Clevers, that TCF/and undergo both positive and negative selection through
LEF1 proteins are downstream targets of the Wnt/Wing-interaction with major histocompatibility complex (MHC)
less signaling pathway shown to control developmentmolecules on thymic epithelium and dendritic cells to
in Drosophila and Xenopus. TCF/LEF proteins mediatebecome SP CD41 helper or CD81 cytotoxic T cells. An
Wnt/Wingless signaling by direct interaction with andever-expanding array of transcription factors and signal-
recruitiment of Armadillo/b-catenin as a transcriptionaling molecules plays distinct roles in each step of this
coactivator (Behrens et al., 1996). However, Tcf factorsselection process as schematized in Figure 3 and de-
can also act as repressors in Drosophila, Xenopus, andtailed at length in an excellent recent review (Kuo and
Caenorhabditis elegans. H. Clevers presented an expla-Leiden, 1999). Here we will focus primarily on those
nation for this transcriptional repression by his demon-transcription factors that uniquely affect the generation
stration that the Xenopus Wnt effector XTcf3 interactsof T cells rather than those such as Ikaros, PU.1, and
with both Groucho-related transcriptional repressorsE2A (as described above), which target a common
and activators (Roose et al., 1998). The interaction of alymphoid±myeloid progenitor and ablate both T and B
single transcription factor with both activator and re-
cell development.
pressor proteins to achieve appropriate expression of
The GATA3 zinc finger transcription factor is posi-
target genes in cell-fate decisions is an area of intense
tioned at the very earliest stages of the T cell lineage. investigation in developmental biology (Gray and Levine,
The differentiation of GATA32/2 ES cells is blocked at 1998) and emerged as a theme of this meeting. The
or before the earliest DN stage of thymocyte develop- identification of activator- and repressor-controlled tar-
ment as evidenced by the complete failure of GATA32/2 get genes for Tcf1 in lymphocytes will be an important
ES cells to contribute to the DN thymocyte population area since such genes can be predicted to be critical
(Ting et al., 1996). As discussed below, GATA3 also in the maintenance of lymphoid stem cells.
influences Th2 differentiation, thus playing a role in mul- Two signaling pathways in addition to Wnt appear to
tiple stages of T cell development. The identification be critical as negative rather than positive regulators for
of GATA3 target genes in the earliest committed DN the generation of T cells. The constitutive activation of
thymocytes as well as in committed mature Th2 cells the p38 MAP kinase pathway in the thymus blocks the
will be an important area of investigation. Lymphoid differentiation of DN into DP thymocytes, suggesting
enhancer factor 1 (LEF1) and T cell factor 1 (TCF1) are that downregulation of p38 kinase activity is important
closely related members of the ªHMG boxº family of for this transition, as presented by M. RincoÂ n. Condi-
transcription factors that regulate the TCRa enhancer tional ablation of the Csk kinase, which inhibits Src fam-
in vitro. Disruption of either the Tcf1 or Lef1 genes results ily kinases (Lck, Fyn) by phosphorylating C-terminal ty-
in an incomplete (Tcf1) or no (Lef1) defect in thymocyte rosine residues, completely overcomes the DN-to-DP
development (Okamura et al., 1998). Thymocytes from block and allows CD4 thymocyte development in both
older mice lacking Tcf1 are arrested at the DN stage (H. TCRb-deficient and MHC class II±deficient mice (Schmedt
Clevers) but, interestingly, T cells can be briefly gener- et al., 1998). A. Tarakovsky speculated that the function
ated (Verbeek et al., 1995). The nature of the defect is of Csk is to make T cell development antigen dependent,
in both the maintenance and the generation of T cells, via the regulation of the two known targets of Csk, Lck
since Tcf12/2 mice have normal T cells at birth but, and Fyn, shown to be sufficient to control CD4 T cell
by 2 weeks of age, have arrested development in the development.
thymus. There is some redundancy between Tcf1 and Interestingly, CD81 cells are not generated in the ab-
sence of Csk, providing support for earlier suggestionsLef1, since double mutant mice have a complete arrest
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that thymocyte commitment to the CD8 and CD4 lin-
eages is asymmetric (Suzuki et al., 1995). CD8 commit-
ment requires MHC-dependent signals while CD4 com-
mitment is MHC-independent and may occur by default
(Suzuki et al., 1995). The molecular basis for this asym-
metry is unknown but may stem in part from differences
in the transcription factors that control the expression
of the coreceptor molecules as DP thymocytes traverse
to the SP stage. An intronic silencer has been reported
to control the tissue-specific expression of CD4 in T
helper cells. It now appears from work presented by G.
Siu that there are at least two factors binding to the
silencer: HES1, a bHLH protein that is a homolog of the
Drosophila Hairy/Enhancer of split (Kim and Siu, 1998),
and a novel homeodomain protein, termed SAF, cloned
by a yeast one-hybrid approach. Mutation of the HES1-
and SAF-binding sites affects function, suggesting for
HES1, that the Notch signaling pathway is important in
thymic development (Kim and Siu, 1998). Interestingly,
E. Robey has recently presented data that constitutive
activation of Notch results in upregulation of HES1 RNA.
One can speculate that the transcription factor Ets1,
critical in the devlopment of natural killer cells, may also
be required to permit the full differentiation of CD8 cells
since CD81 Ets1-deficient T cells express low levels of
Figure 4. Transcription Factors that Control T Helper Lineage Com-CD4 (Kuo and Leiden, 1999). J. Leiden hypothesizes that
mitmentEts1 may control the expression of important proximal
signal transduction molecules whose dysregulation re-
sults in abnormal CD8 T cell development. TCR chain gene have been identified. Although the de-
Csk may allow cells to adapt to signals of varying velopment of the gd lineage is distinct from ab, data
strength by altering threshholds of T cell activation (A. presented at this meeting suggest that there is recipro-
Tarakhovsky). An interesting theme that emerged from cal regulation between them evident at the level of tran-
this meeting is that transcription factors also control scription. Using in vivo footprinting, M. Krangel and col-
signaling threshholds in lymphocytes, similar to the reg- league C. Hernandez-Munain demonstrated that the
ulation of development in Drosophila and C. elegans occupancy of the CBF, Myb, and GATA sites in the d
by transcription factor gradients. K. Georgopoulos re- enhancer in DN cells decreases at the DP stage at the
ported that disruption of the Ikaros gene in lymphocytes
time when the Ea enhancer is active. This may serve as
leads to a decreased number of peripheral T cells that
a mechanism to prevent previously rearranged (in frame)
both hyperproliferate and enter the cell cycle more rap-
d genes from being expressed in cells that are differenti-idly than wild type, with a shortened G1 phase. A similar
ating along the ab pathway. A related series of experi-phenotype is observed in T cells from mice lacking both
ments emphasizes the value of looking at promoter oc-the NFATp and NFAT4 transcription factors (L. Glim-
cupancy in vivo to ascertain both accessibility ofcher), while lymphocytes lacking NFATc have the oppo-
chromatin to factor binding and cooperative interactionssite phenotype (Ranger et al., 1998a; Yoshida et al.,
between transcription factors. Thus, M. Krangel re-1998). E. Serfling suggested (see below) that alternative
ported that sites in the Ea enhancer were occupiedpolyadenylation of NFATc might be one mechanism to
in DN cells of Rag2/2 mice despite the absence of Eagenerate high threshhold levels after stimulation in T
transcripts, and that mutation of either the Tcf/Lef oreffector cells. The downstream target genes for these
Ets site in the Ea enhancer resulted in generalized failurefactors are largely unknown but may be involved in the
of enhancer occupancy at all other sites (Hernandez-maintenance of the resting state, in control of the cell
Munain et al., 1998).cycle, or in the regulation of a T cell±specific death
Transcription Factors that Control T Helperpathway. One interesting candidate is the gene encod-
Cell Developmenting the LKLF transcription factor, recently shown by
Naive CD41 T helper precursor cells respond to antigenLeiden and colleagues to be critical both in controlling
by differentiating along a Th1 (IFN-g, IL-2) or Th2 (IL-4,the DP-to-SP transition in the thymus and in maintaining
-5, -6, -9, -10, -13) pathway (Figure 4). These two subsetsT cell quiescence in the periphery (Kuo et al., 1997).
of Th cells are defined by the patterns of cytokines theyThe hyperactivation and increased rates of apoptosis
produce. This differentiation is highly dependent on theof LKLF2/2 T cells suggest that the maintenance of qui-
presence of certain cytokines and their downstream sig-escence is not a passive process, but one actively regu-
naling transcription factors. Thus, Th1 and Th2 develop-lated at the level of transcription.
ment do not occur in the absence of IL-12/Stat4 (Thier-At the DN stage, the T cell lineage splits to generate
felder et al., 1996; Kaplan et al., 1996b) and IL-4/Stat6two distinct types of T cells, distinguished by the type
(Kaplan et al., 1996a), respectively. Using in vivo DNaseof T cell receptor they bearÐTCRab and TCRgd. Tran-
scription factors that regulate the expression of each I hypersensitivity assays to assess locus accessibility,
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A. Rao reported rapid chromatin remodeling and CpG al., 1997). Nevertheless, the phenotype of mice deficient
in either NFATp or NFATc suggested a Th-selectivedemethylation as demonstrated by the acquisition of
tissue-specific hypersensitive sites, after antigen stimu- and reciprocal role for these proteins in regulating the
balance of Th1/Th2 responses. Severe reductions inlation and polarization of both naive and mature effector
T cells (Agarwal and Rao, 1998). Coordinate remodeling IL-4 production were noted in NFATc2/2 lymphocytes
(Ranger et al., 1998a; Yoshida et al., 1998), while en-of the IL-4/IL-13/IL-5 locus on chromosome 11 and at
the IFN-g locus in Th2 and Th1 cells, respectively, was hanced IL-4 production was observed in NFATp2/2 mice
(Hodge et al., 1996b; Xanthoudakis et al., 1996). L.observed. She suggested a two-step model in which
antigen-driven chromatin remodeling is followed by anti- Glimcher reported that mice lacking both NFAT4 and
NFATp had extreme and selective activation of the Th2gen- and cytokine-dependent occupancy of DNA by
tissue-specific transcription factors. compartment accompanied by constitutive nuclear lo-
calization of NFATc, suggesting a repressor role forConsiderable progress has recently been made in
identifying such tissue-specific factors for the develop- NFATp and NFAT4 and an activator role for NFATc in
controlling Th2 development and activation (Ranger etment of the Th2 compartment. c-Maf is a Th2-specific
basic region/leucine zipper protein that transactivates al., 1998b). What is the mechanism by which different
NFAT proteins selectively regulate distinct cytokines?the IL-4 promoter in vitro (Ho et al., 1996; Hodge et al.,
1996a). The provision of three factors, the Th2-specific There may be several levels of control, including tran-
scriptional and posttranslational regulation of NFAT.c-Maf protooncogene, NFAT, and an NFAT-interacting
protein, NIP45, has been previously shown to reconsti- NFATc for example is present in alternatively spliced
isoforms that differ in naive and activated T cells (E.tute endogenous IL-4 production in nonproducer cells
(Hodge et al., 1996a). The phenotypes of c-Maf and Serfling). A host of different kinases including GSK3,
JNK, and CKIa, that regulate NFAT nuclear export haveNFAT genetic mutant mice recently produced provide
compelling evidence that c-Maf and NFAT proteins con- recently been described (Beals et al., 1997; Zhu et al.,
1998), some of which phosphorylate only the NFAT4trol the Th2 differentiative program (Mach et al., 1994;
Ho et al., 1998; Oukka et al., 1998; Ranger et al., 1998a, protein (Chow et al., 1997). C. Dong from the Flavell
laboratory reported that Th cells from JNK1-deficient1998b). Evidence for a critical role for c-Maf in driving
IL-4 production in normal T cells was provided by stud- mice were hyperresponsive to TCR stimulation and pref-
erentially became Th2 effector cells (Dong et al., 1998).ies reported by L. Glimcher demonstrating overproduc-
tion of Th2 cytokines in c-Maf overexpressor transgenic This phenotype was similar to that of mice lacking
NFATp and also was accompanied by constitutive nu-mice and severely impaired IL-4 production in mice lack-
ing c-Maf. Since c-Maf-deficient T cells can produce clear localization of NFATc as described by Glimcher
(Ranger et al., 1998b). J. Redondo described yet anothersmall amounts of IL-4 when stimulated with exogeneous
IL-4, it is likely that IL-4-responsive factors such as MAP kinase, p38, to be involved in the nuclear export
of NFATp. It is probable that different signaling pathwaysGATA3 (Zheng and Flavell, 1997) and Stat6 may also
contribute to Th2 development. Indeed, mice lacking will regulate distinct NFATs in a cell-type specific man-
ner. It is also likely that NFAT proteins balance Th differ-Stat6 do not develop Th2 cells (Kaplan et al., 1996a),
while mice overexpressing GATA3 have an increased entiation both by partnering with distinct coactivators
and repressors and by inducing distinct sets of targetnumber of Th2 cells (Zheng and Flavell, 1997). However,
unlike c-Maf, GATA3 probably does not directly regulate genes. Known NFAT target genes include cytokines,
fasL, and CD40L receptors, but there will surely be oth-IL-4 transcription although it clearly does directly trans-
activate the IL-5 gene (Zhang et al., 1997; Ouyang et al., ers. Two newly identified NFAT target genes were re-
ported to be the IL-2 receptor a chain (CD25) (Schuh et1998). It may instead act further upstream, perhaps as
a chromatin remodeling factor, to make the IL-4/IL-5 al., 1998) and cyclooxygenase 2 (Cox2), shown to be an
immediate early gene in T cells (M. Fresno). M. Fresnolocus accessible. Another transcription factor, C/EBPb,
has been shown to specifically increase transcription of reported that Cox2 is both regulated by NFAT and itself
regulates NFAT activity. The identification of NFAT ki-the human IL-4 gene (Li-Weber et al., 1997) although its
expression is not Th2-limited in murine cells (Ho et al., nases that affect NFAT activity in vivo as well as the
isolation of additional NFAT target genes will be critical1996). In sum, while significant advances have been
made in identifying a set of transcription factors impor- in understanding how NFAT proteins balance the Th
immune response.tant in developing the Th2 lineage, much remains to be
learned about how this set of Th2-specific transcription Much less is known about factors that control Th1
development. Mice lacking IL-12 or its downstream sig-factors are regulated in response to extracellular signals,
as well as the nature of the combinatorial interactions naling factor, Stat4, do not develop Th1 cells (Kaplan et
al., 1996b; Thierfelder et al., 1996). Th1 cells are alsothat occur on Th2 cytokine promoters. Furthermore,
there is some evidence that a balance between repres- lacking in mice deficient for the transcription factor
IRF-1, likely through its direct effect in controlling trans-sors and activators is required to maintain a Th1/Th2
balance. Thus, the transcription factor Bcl6 may com- cription of the IL-12 gene (Lohoff et al., 1997; Taki et
al., 1997). Activation of the p38 MAP kinase pathway bypete with Stat6 to control the development of the Th2
lineage as demonstrated by the profound Th2 pheno- the expression of constitutively activated MAP kinase
kinase 6 (MKK6) boosts IFN-g production, while block-type of mice lacking Bcl6 (Dent et al., 1997).
Three of the four known NFAT proteins are expressed ade of this pathway by expression of a dominant nega-
tive p38 MAP kinase or by targeted disruption of JNK2in both Th1 and Th2 cells and can transactivate both
Th1 and Th2 cytokine gene promoters in vitro (Rao et partially impairs Th1 responses (RincoÂ n et al., 1998;
Cell
20
Yang et al., 1998). Further, Th1 cell development is cases transformation. In the ªmultistepº model of carci-
somewhat impaired in the absence of JNK1, consistent nogenesis, a single genetic alteration is insufficient to
with its placement upstream of p38 and downstream of achieve transformation but requires other cooperating
MEKK6 (Dong et al., 1998). The mechanism by which cell alterations. The dysregulation of cell growth ob-
the JNK2 signaling pathway affects Th1/Th2 balance is served in the absence of the transcription factors de-
unknown but might be via a direct effect on transcription scribed above may serve as the ªfirst hitº and also result
of the IFN-g gene. Possible downstream targets include in an increased tendency for a ªsecond hitº to occur,
the ATF-2 and AP-1 transcription factors, both sub- leading to frank transformation. Several examples were
strates of Jnk kinases and also known to bind to sites provided at this meeting. A dominant-negative mutation
in the IFN-g promoter. However, we still do not know in the Ikaros gene leads to rapid development of lym-
the identity of the transcription factors responsible for phoma and leukemia (Winandy et al., 1995), while Ikaros
the tissue-specific expression of IFN-g or other Th1 cy- null mice also develop lymphomas albeit at a slower
tokines in Th1 cells. Unless the Th1 pathway is a default pace (K. Georgopoulos). H. Clevers reported that in co-
pathway, we should expect there to be factors equiva- lonic epithelium deficient for APC, constitutive activity
lent to c-Maf and GATA3 that drive this lineage. Alterna- of Tcf4, closely related to the lymphoid specific Tcf1, and
tively, transcription factors that act as activators in Th2 also a downstream effector of Wingless/Wnt signaling,
cells might have an equally important but opposing func- results in transformation while the absence of Tcf4 re-
tion as repressors in Th1 cells. In this regard it is intri- sults in depletion of epithelial stem cell compartments
guing that both c-Maf and GATA3 partially inhibit pro- (Korinek et al., 1998). Since absence of Tcf1 similarly
duction of the Th1 cytokine IFN-g (Ho et al., 1998; results in the depletion of the lymphoid stem cell com-
Ouyang et al., 1998). The relationship between signaling partment, it could be predicted that constitutive expres-
threshhold levels and Th1/Th2 balance is also intriguing. sion of Tcf1 will lead to lymphoid tumors. C. Scheidereit
Lowering this threshhold appears to favor formation of reported that constitutive nuclear activity of the NF-
Th2 cells as exemplified by the phenotype of mice lack- kB p65 and p50 heterodimer is present in the Reed-
ing NFATp and NFAT4. It will be of interest to determine Sternberg cells of Hodgkins disease and this constitu-
the role of Th1-specific transcription factors, when they tive activation is secondary either to loss of functional
are isolated, on T cell proliferative responses. IkBa or to aberrant constitutive IkB kinase activation
An interesting point to emerge from this meeting was (Bargou et al., 1997; Krappmann et al., 1999). Blocking
that signaling proteins and/or transcription factors act
endogeneous NF-kB suppresses proliferation of these
at multiple stages of T cell differentiation. GATA3 is a
malignant cells. Are the IkB proteins and these other
critical regulator of both early T cell development and
transcription factors in fact tumor suppressors, and ifthe transition of a mature Th precursor cell to the Th2
so, what is the mechanism by which they affect cellularlineage, consistent with the presence of GATA3-binding
proliferation? Current investigations focus on the role ofsites in the promoters of many T cell±specific genes
these factors in interacting with the cell cycle machinery.(Ting et al., 1996). Alteration of the Erk/Jnk pathway
Preliminary data was presented by C. Scheidereit thataffects both thymocyte development and mature Th dif-
NF-kB activity is required for the G1/S transition inferentiation, while NFAT4 plays a role both in generation
mouse embryonic fibroblasts via controlling the rate ofand survival of thymocytes and in determining the acti-
pRb phosphorylation. NF-kB also directly transactivatesvation state of peripheral T lymphocytes (Oukka et al.,
the cyclin D promoter (M. Hinz et al., submitted). Uncov-1998). Further, the demonstration that chromatin remod-
ering the relationship between transcription and trans-eling is involved in a very early stage of cytokine induc-
formation for factors involved in T and B cell develop-tion (Agarwal and Rao, 1998) implies that the NFAT, Stat,
ment will be a hotly investigated area for the future.GATA3, and c-Maf transcription factors may also act at
Conclusionsthis step as well as at the step of acute induction of
The B and T lineages of the lymphoid system representtranscription. Transcription factors can simultaneously
leading models for analysis of developmental pathwaysaffect the development of the T and the B lineages.
in mammals. The Juan March meeting provided a uniqueThus, Ets1 is necessary to achieve a normal thymocyte
forum for presentations on transcription factors that or-number and is also required to prevent spontaneous
chestrate development of these related lineages. The Bdifferentiation of B cells into plasma cells (Kuo and
and T lineages share two key developmental principles,Leiden, 1999). Clearly, it will be necessary to identify the
namely (1) assembly of antigen receptor gene segmentsinteracting partners and patterns of gene expression
utilizing a common recombination apparatus and (2) useinduced by each of these transcription factors in the
of rearranged Ig heavy chain or TCRb genes to regulatethymus versus the peripheral lymphoid compartment.
key developmental transitions. It is interesting to noteTranscription Factors that Control Lymphocyte
that of the various transcription factors required for lym-Proliferation and Transformation
phocyte development, the Ikaros and related family ofMany examples now exist of tumorigenesis arising from
proteins may perform shared molecular functions in reg-deregulation of transcription factor function consequent
ulating both the development and proliferation of B andto chromosomal translocations. However, transcription
T lineage cells. These functions would include repres-factors may also promote or impede tumorigenesis by
sion of lineage-inappropriate genes and setting thresh-other mechanisms as exemplified by the anti-onco-
olds for lymphocyte activation. Considerable progressgenes or ªtumor suppressorsº p53 and Rb. We have
is being made in identifying and analyzing regulatorsmentioned earlier that certain of the factors discussed
that function to specify cell fate decisions at variousabove negatively control signaling threshholds in lym-
phocytes, leading to hyperproliferation and in some nodal points in the lymphoid system, for example, during
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Control of inflammation, cytokine expression, and germinal centerthe generation of (1) B versus T lineage progenitors, (2)
formation by BCL-6. Science 276, 589±592.CD41 vs CD81 single-positive T cells, and (3) Th1 versus
Dong, C., Yang, D.D., Wysk, M., Whitmarsh, A.J., Davis, R.J., andTh2 helper T cells. In the latter two cases, signaling
Flavell, R.A. (1998). Defective T cell differentiation in the absencepathways involving Notch or cytokine receptors (IL-12R,
of Jnk1. Science 282, 2092±2095.
IL-4R), respectively, appear to induce cell fate specifica-
Fitzsimmons, D., Hodsdon, W., Wheat, W., Maira, S.M., Wasylyk, B.,
tion. Lineage specification in each instance seems to and Hagman, J. (1996). Pax-5 (BSAP) recruits Ets proto-oncogene
involve positive regulation of the lineage-appropriate family proteins to form functional ternary complexes on a B-cell-
gene set and active repression of lineage-inappropriate specific promoter. Genes Dev. 10, 2198±2211.
genes. Transcription factors function in a combinatorial Gray, S., and Levine, M. (1998). Transcriptional repression in devel-
opment. Curr. Opin. Cell. Biol. 8, 358±364.capacity at two distinct levels: (1) in specifying lineage
Hernandez-Munain, C., Roberts, J.L., and Krangel, M.S. (1998). Co-fates perhaps by establishing stable cross-regulatory
operation among multiple transcription factors is required for accessnetworks and (2) in regulating lineage-specific structural
to minimal T-cell receptor a-enhancer chromatin in vivo. Mol. Cell.genes by assembling specific multiprotein DNA com-
Biol. 18, 3223±3233.
plexes. Thresholds of signaling molecules and transcrip-
Ho, I.-C., Hodge, M.R., Rooney, J.W., and Glimcher, L.H. (1996). The
tion factors likely regulate proliferation and differentia- proto-oncogene c-maf is responsible for tissue-specific expression
tion of lymphocytes and their progenitors. Molecular of interleukin-4. Cell 85, 973±983.
analysis of such thresholds will be a key area for further Ho, I.-C., Lo, D., and Glimcher, L.H. (1998). C-maf promotes Th2
investigation. and attenuates Th1 differentiation by both IL-4 dependent and inde-
pendent mechanisms. J. Exp. Med. 188, 1859±1866.
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